 |
|
Refractory Status Epilepticus
Effect of Treatment Aggressiveness on Prognosis
Andrea O. Rossetti, MD;
Giancarlo Logroscino, MD, PhD;
Edward B. Bromfield, MD
Arch Neurol. 2005;62:1698-1702.
Background Administration of antiepileptic drugs for coma induction in refractory status epilepticus (RSE) has not been widely studied. Moreover, the effect on outcome of electroencephalographic (EEG) burst suppression remains unclear.
Objective To investigate whether various coma-inducing options are associated with different prognoses after RSE.
Design Retrospectively assessed case series.
Setting Two tertiary referral hospitals in Boston, Mass.
Patients Among 127 consecutive episodes (107 patients) of status epilepticus, we identified episodes that were refractory to first-line and second-line antiepileptic drugs, needing induced coma with barbiturates, propofol, or midazolam for clinical management.
Main Outcome Measures Short-term mortality and prevalence of return to functional baseline after the acute episode of status epilepticus were analyzed in relation to demographic and clinical variables and to treatment option (antiepileptic agents and EEG burst suppression).
Results Forty-nine episodes of RSE (47 patients) were found, occurring more frequently in incident than in recurrent episodes of status epilepticus (P = .06). Mortality was 23% for patients with RSE and 8% for those without RSE (P = .05). Return to baseline occurred more often in the non-RSE group (P = .04). In 20 (61%) of 33 monitored episodes, EEG burst suppression was achieved. Demographic data, clinical variables, and outcome did not differ significantly with the various coma-inducing agents or between episodes with and without EEG burst suppression.
Conclusions Refractory status epilepticus is more prevalent in incident than in recurrent status epilepticus and is associated with higher mortality; clinical status is less likely to return to baseline than with non-RSE. Outcome was independent of the specific coma-inducing agents used and the extent of EEG burst suppression, suggesting that the underlying cause represents its main determinant.
Author Affiliations: Department of Neurology, Division of Epilepsy and EEG, Brigham & Women’s Hospital, Harvard Medical School (Drs Rossetti and Bromfield), and Harvard School of Public Health (Dr Logroscino), Boston, Mass.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Treatment of Acute Seizures and Status Epilepticus
Costello and Cole
J Intensive Care Med 2007;22:319-347.
ABSTRACT
In-hospital mortality of generalized convulsive status epilepticus: A large US sample
Koubeissi and Alshekhlee
Neurology 2007;69:886-893.
ABSTRACT
| FULL TEXT
Status epilepticus: An independent outcome predictor after cerebral anoxia
Rossetti et al.
Neurology 2007;69:255-260.
ABSTRACT
| FULL TEXT
Comparative Efficacy and Safety of Antiepileptic Drugs for the Treatment of Status Epilepticus
Chung et al.
Journal of Pharmacy Practice 2007;20:137-146.
ABSTRACT
Generalised convulsive status epilepticus: an overview
Nandhagopal
Postgrad. Med. J. 2006;82:723-732.
ABSTRACT
| FULL TEXT
Prognosis of status epilepticus: role of aetiology, age, and consciousness impairment at presentation
Rossetti et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:611-615.
ABSTRACT
| FULL TEXT
|
